Safe Supply to sell two Nirlab devices to first nation

Executive Summary

• Safe Supply Streaming Co. Ltd. announced the sale of two Nirlab SA drug analysis devices to a First Nation community to support local safety, health, and emergency response initiatives.
• The transaction expands access to rapid, field-deployable drug identification technology within Indigenous communities, aiming to enhance informed decision-making and front-line response capabilities in areas with limited laboratory access.
• Management highlighted the transaction as evidence of continued demand for deployable drug analysis solutions in real-world field and community settings, reinforcing the relevance of their technology.

Key Details

• Transaction: Sale of two Nirlab SA drug analysis devices.
• Buyer: A First Nation community.
• Purpose: To support local safety, health, and emergency response initiatives; specifically to help identify unknown or potentially hazardous substances.
• Strategic Context: This follows an initial Nirlab sale and demonstrates expanding adoption across Indigenous-led initiatives and remote applications.
• Technology Capabilities: Nirlab devices provide rapid, non-destructive substance analysis in the field, supporting applications in community safety, emergency response, institutional environments, and public health.
• Future Outlook: The company continues to evaluate additional opportunities for Nirlab deployments with community organizations, institutional users, and government-aligned stakeholders.

Notable Quotes

• "This transaction reflects continued demand for deployable drug analysis solutions in real-world field and community settings," said Geoff Benic, chief executive officer of Safe Supply. "Following our initial Nirlab sale, we are encouraged to see expanding adoption across indigenous-led initiatives and remote applications, reinforcing the relevance of field-based analytical tools."
• "We believe access to rapid, field-deployable analytical technology can play a meaningful role in supporting preparedness and informed decision making in settings where laboratory resources may be limited," said Raf Souccar, chairman of the board of Safe Supply.